Reference | Region | Location / data collection period | Locally advanced stage of cervical cancer | N | Race or ethnic group |
Garg et al*8 2011 | North America | USA 1988–2005 | IIA1 | 271 | Black, 10.7% White, 72.7% Other, 16.6% |
IIA2 | 289 | Black, 10.4% White, 75.8% Other, 13.8% | |||
Hou et al†16 2019 | North America | USA 1988–2011 | II, 11.6% III, 6.9% Total LACC, 18.5% | 3953 | Asian American |
II, 4.8% III, 3.1% Total LACC, 7.9% | 54 827 | White | |||
Bruegl et al†15 2020 | North America | USA Idaho, Oregon, & Washington 1996–2016 | Regional, 33.9% | 221 | AI/AN |
Regional, 29.9% | 7001 | Non-Hispanic White | |||
Tian et al‡9 2020 | North America | USA 2010–2015 | Squamous cell, all LACC stages | 3385 | Black, 16.8% White, 73.1% Other, 10.1% |
Adenocarcinoma, all LACC stages | 746 | Black, 7.9% White, 79.9% Other, 12.2% | |||
Carmo et al18 2011 | South America | Brazil Rio de Janeiro 1999–2004 | II | 1133 | Non-White, 42.9% White, 57.1% |
III | 1216 | Non-White, 47.0% White, 53.0% |
*The Garg 2011 study8 only included patients with stage IIA cervical cancer, with analyses comparing IIA1 and IIA2.
†The Hou 2019 study16 only included patients who were Asian American or White. The Bruegl 2020 study15 only included patients who were AI/AN or non-Hispanic White.
‡The Tian 2020 study9 only included patients with LACC stages of disease and squamous cell or adenocarcinoma histology; patients with squamous cell and adenocarcinoma histology were separated for all analyses.
AI/AN, American Indian/Alaskan Native; LACC, locally advanced cervical cancer.